Article
Phenotype-driven de novo molecular design from gene expression signatures
2026-07-24
Abstract excerpt
<h4> A bstract </h4> Target-based and structure-guided drug design remain central to modern drug discovery, but complementary strategies are needed when predefined targets or binding pockets do not fully capture disease biology. Gene-expression signatures provide scalable system-level readouts of disease and perturbation states, making them attractive inputs for phenotype-guided molecular design. However, prese...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 26290b94-86e1-5216-ac7a-eeabc7efc221
- DOI
- 10.64898/2026.07.21.739736
